Reps Schrier, Langworthy Introduce Bipartisan Bill to Lower Prescription Drug Costs by Expanding Access to Biosimilars
Food and Drug Administration's (FDA) biosimilar approval process, reduce unnecessary regulatory barriers, and help bring lower-cost … time the Food and Drug Administration improve the approval process for biosimilars, which are lower-cost, lifesaving